Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "IND"

7614 News Found

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR
News | April 30, 2026

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR

CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart


JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation
Policy | April 30, 2026

JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation

Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services


Granules India  Q4FY26 revenue jumps 23% to Rs 14,706 million; FY26 revenue at Rs 53,656 million
News | April 29, 2026

Granules India Q4FY26 revenue jumps 23% to Rs 14,706 million; FY26 revenue at Rs 53,656 million

The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform


Apollo launches its 76th hospital, boosts tech-led healthcare in India
Hospitals | April 28, 2026

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof


Stryker launches Trident II Hip System in India
Medical Device | April 28, 2026

Stryker launches Trident II Hip System in India

New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


Essilor Stellest lens positioned as key breakthrough in myopia control in India
News | April 28, 2026

Essilor Stellest lens positioned as key breakthrough in myopia control in India

The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025


LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
Hospitals | April 27, 2026

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%